Comparison Chart Madrigal Pharmaceuticals, Inc.
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:44:28 18/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 407.93 USD | -3.33% |
|
-5.92% | -30.04% |
| 11-17 | Madrigal Pharmaceuticals, Inc. Presents at Jefferies London Healthcare Conference, Nov-17-2026 10:30 AM | |
| 11-06 | HEALTH ROUNDS-New blood test matches gold standard for liver disease diagnosis | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -3.21% | -5.92% | -30.04% | -27.12% | +388.79% | 9.8B |
- Stock Market
- Stocks
- MDGL Stock
- Charts Madrigal Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















